Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?

by Marco Bisaglia, Luigi Bubacco
Published 2020-01-01

DJ-1 as a deglycating enzyme: A unique function to explain a multifaceted protein?

by Federica De Lazzari, Marco Bisaglia
Published 2017-01-01

Antioxidant Therapy in Parkinson’s Disease: Insights from <i>Drosophila melanogaster</i>

by Federica De Lazzari, Federica Sandrelli, Alexander J. Whitworth, Marco Bisaglia
Published 2020-01-01

Circadian Rhythm Abnormalities in Parkinson’s Disease from Humans to Flies and Back

by Federica De Lazzari, Marco Bisaglia, Mauro Agostino Zordan, Federica Sandrelli
Published 2018-12-01

Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease

by Alice Biosa, Federica Sandrelli, Mariano Beltramini, Elisa Greggio, Luigi Bubacco, Marco Bisaglia
Published 2017-12-01

Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease.

by Elisa Belluzzi, Marco Bisaglia, Elisabetta Lazzarini, Leandro C Tabares, Mariano Beltramini, Luigi Bubacco
Published 2012-01-01

DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury

by Federica De Lazzari, Hiran A. Prag, Anja V. Gruszczyk, Alexander J. Whitworth, Marco Bisaglia
Published 2021-05-01

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation.

by Roberta Filograna, Laura Civiero, Vanni Ferrari, Gaia Codolo, Elisa Greggio, Luigi Bubacco, Mariano Beltramini, Marco Bisaglia
Published 2015-01-01

Covalent α-synuclein dimers: chemico-physical and aggregation properties.

by Micaela Pivato, Giorgia De Franceschi, Laura Tosatto, Erica Frare, Dhruv Kumar, Daniel Aioanei, Marco Brucale, Isabella Tessari, Marco Bisaglia, Bruno Samori, Patrizia Polverino de Laureto, Luigi Bubacco
Published 2012-01-01